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Abstract: Background: Flavonoids exert anti-inflammatory properties and modulate oxidative stress
in vitro, suggesting a protective effect on lung function, but epidemiological studies examining this
association are scarce. Methods: A stratified random sample was drawn from the GA2LEN screening
survey, in which 55,000 adults aged 15 to 75 answered a questionnaire on respiratory symptoms.
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Post-bronchodilator spirometry was obtained from 2850 subjects. Forced vital capacity (FVC), the ratio
between the forced exhaled volume in 1 second (FEV1) and FVC (FEV1/FVC), FVC below lower limit
of normal (FVC < LLN), and FEV1/FVC < LLN were calculated. Intake of the six main subclasses of
flavonoids was estimated using the GA2LEN Food Frequency Questionnaire. Adjusted associations
between outcomes and each subclass of flavonoids were examined with multivariate regressions.
Simes’ procedure was used to test for multiple comparisons. Results: A total of 2599 subjects
had valid lung function and dietary data. A lower prevalence of FVC < LLN (airway restriction)
was observed in those with higher total flavonoid (adjusted odds ratio (aOR), higher vs. lowest
quintile intake 0.58; 95% Confidence Interval (CI) 0.36, 0.94), and pro-anthocyanidin intakes (aOR
0.47; 95% CI 0.27, 0.81). A higher FEV1/FVC was associated with higher intakes of total flavonoids
and pro-anthocyanidins (adjusted correlation coefficient (a β-coeff 0.33; 0.10, 0.57 and a β-coeff
0.44; 95% CI 0.19, 0.69, respectively). After Simes’ procedure, the statistical significance of each of
these associations was attenuated but remained below 0.05, with the exception of total flavonoids
and airway restriction. Conclusions: This population-based study in European adults provides
cross-sectional evidence of a positive association of total flavonoid intake and pro-anthocyanidins
and ventilatory function, and a negative association with spirometric restriction in European adults.
Keywords: flavonoids; pro-anthocyanidins; lung function; GA2LEN
1. Introduction
Flavonoids are polyphenolic plant secondary metabolites ubiquitously present in vegetables,
fruits, and beverages. Various biological properties of relevance for lung health have been
identified for these compounds, including antioxidant, anti-allergic, and immune-modulating
activities [1]. There is a considerable body of experimental evidence (in vivo and in vitro) on
the anti-inflammatory properties of flavonoids, particularly pro-anthocyanidins, on lung health.
Experimental evidence shows that pro-anthocyanidins can reduce lung mRNA expression of
pro-inflammatory cytokines such as Interferon-γ, Interleukin (IL)-4, and IL-13 [2], and down-regulate
nitric oxide production in asthma [3]. Trifolirhizin, another flavonoid, has been demonstrated to inhibit
in a dose-response manner, the production of IL-6 and tumour necrosis factor-α (TNF-α) in lung cancer
cells [4]. Pro-anthocyanin-enriched blackcurrant extract and epigallocatechins were shown to reduce
eosinophilic-driven airway inflammation in human alveolar cells [5].
Epidemiological studies have shown a beneficial effect of a higher intake of fruits and vegetables
on chronic respiratory health in adults, most of which refers to incidence of asthma and chronic
obstructive pulmonary disease (COPD) [6,7] or to prevalence of asthma symptoms [8]. These benefits
have been attributed to the high content of flavonoids present in hard fruits such as apples [9,10],
though this effect was not confirmed in one population-based study [11]. Epidemiological evidence on
the association between flavonoids and lung function is scant and limited to the assessment of few
flavonoid subclasses (e.g., flavonols and flavan-3-ols). A recent population-based study in young adults
found that a higher forced vital capacity (FVC) was associated with a higher intake of catechins and of
total fruit [12]. There are also observational studies showing a slower decline of forced exhale volume
in 1 second (FEV1) [13,14] and FVC [14], indirectly attributed to flavonoids. In asthmatic subjects,
a higher FEV1 was associated with having a higher intake of soy genistein (a type of polyphenol) [15].
The GA2LEN survey is the first multi-national, population-based study investigating the role
of all main major subclasses of flavonoids on ventilatory function in a representative sample of
European adults.
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2. Materials and Methods
2.1. The GA2LEN Study: Screening and Clinical Surveys
The core protocol for the GA2LEN survey required 18 European participating centres to identify
a random sample of at least 3000 adults aged 15–74 years from an available population-based sampling
frame. In 2008–2009, potential participants were sent a short questionnaire by mail, and at least three
attempts were made to elicit a response. The questionnaire collected information on age, gender,
smoking, and the presence of symptoms of asthma (including age of onset), chronic rhino-sinusitis,
and allergic rhinitis. Four sub-samples were selected to define cases and controls: (1) those with
self-reported asthma and at least one respiratory symptom reported in the last 12 months (‘asthma’);
(2) those having chronic sinusitis (defined following the European Position Paper on Rhinosinusitis and
Nasal Polyps (EP3OS) Group criteria, that is, the presence of at least two of the following symptoms
for at least 12 weeks in the past year: (i) nasal blockage, (ii) nasal discharge, (iii) facial pain or pressure,
or (iv) reduction in sense of smell with at least one of the symptoms being nasal blockage or nasal
discharge); (3) those who had both ‘asthma’ and ‘chronic sinusitis’; and (4) those who had none of
these conditions [16].
Participants selected were invited in for further tests. Relevant to this analysis they had performed
spirometry using a New Diagnostic Design (NDD) Easy-One spirometer before and after 200 µg of
short-acting beta-agonist, salbutamol inspired through a Clement Clarke Able spacer. After at least
three acceptable and two reproducible maneuvers were obtained by trained technicians, the lung
function was defined as the highest of two values for FVC and FEV1 taken from acceptable forced
expiratory maneuvers that did not vary by more than 200 mL. Only spirometry that met the European
Respiratory Society/American Thoracic Society (ERS/ATS) criteria were accepted [17]. All spirometries
were checked centrally for quality control.
2.2. Estimates of Diet and Flavonoid Intake
Usual consumption of 250 foods was estimated using the GA2LEN food frequency questionnaire
(FFQ), which was designed to assess dietary intake across countries in Europe using a single,
standardised instrument, and validated in five countries participating in GA2LEN ClinicalTrials.gov
Identifier: NCT03251157) [18]. The FFQ collected data on a wide range of foods, including 37 vegetables
and 28 fruits, as well as foods rich in soy and grains. The FFQ also included a general question to
ascertain use of nutritional supplements (‘Do you regularly take any nutritional supplements?’).
On the FFQs, respondents sometimes left individual items blank. This was assumed to denote zero
intake of these foods; however, if 20% of the items were blank, the FFQ was considered incomplete,
and the subject was excluded from further analyses. Participants were also excluded if they had
extreme values of total energy intake, which might suggest an unrealistic response. We calculated the
expected basal metabolic rate (BMR) with the given age, weight, and sex, and excluded subjects with
a ratio of energy intake to expected BMR that was either below the 0.05th sample centile or above the
99.5th sample centile for their country.
Total energy intake (TEI) was calculated using the latest available food composition estimates
from the British Food Composition Table [19]. A database for the assessment of intakes of different
flavonoid subclasses was constructed. We used the updated and expanded US Department of
Agriculture (USDA) flavonoid content of foods and the pro-anthocyanidin databases [20,21]. Intakes
were derived for the six main flavonoid subclasses habitually consumed in general population [22]:
(1) flavanones (eriodictyol, hesperetin, and naringenin); (2) anthocyanins (cyanidin, delphinidin,
malvidin, pelargonidin, petunidin, and peonidin); (3) flavan-3-ols (catechins and epicatachins);
(4) flavonols (quercetin, kaempferol, myricetin, and isohamnetin); (5) flavones (luteolin and apigenin);
and (6) polymers (proanthocyanidins, theaflavins, and thearubigins). Total flavonoid intakes were
derived by the addition of the six component subclasses. We also examined associations with the
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pro-anthocyanidins subclass, which were derived separately, summing monomers, dimers, trimers, 4-
to 6-mers, 7- to 10-mers, and >10-mers.
2.3. Statistical Analyses
Sampling probability weights were used to standardise prevalences by gender and age to
a European Standard Population. For each centre, the sample mean of the FEV1/FVC ratio and the FVC
was estimated as well as the sample prevalence of a low FEV1/FVC ratio or a low FVC according to
the National Health and Nutrition Examination Survey (NHANES) III norms for Caucasians. For each
flavonoid group, total intake was split into quintiles. For each centre, the odds of the FEV1/FVC
ratio being below the lower limit of normal comparing the lowest and highest quintile of flavonoid
consumption was calculated. These odds ratios for all centres were then combined into a single estimate
using random effects meta-analysis [23]. For continuous measures of lung function (FEV1/FVC and
FVC), their association with each flavonoid subclass was assessed against the per-quintile increase
of each flavonoid subclass. Associations were examined using two models of adjustments. Model 1
included adjustment for height, age, and sex, and Model 2 added the variables whether a case or
a control (as defined in the GA2LEN survey), body mass index (BMI), smoking status (never, ex-smoker,
current smoker), occupation, age at completion of full time education, use of nutritional supplements,
total fruit and vegetable intake, and TEI. Simes’ procedure was used to correct statistical estimates
derived from multiple testing [24].
We examined the correlation of each of the subclasses of flavonoids and these ranged between
0.28 (flavan-3-ols) and 0.40 (pro-anthocyanidins), therefore we did not use energy-adjusted values of
flavonoids and instead adjusted for TEI in the models.
Written informed consent was obtained from all participants. The GA2LEN Follow-Up Survey
was granted ethical approval by the UK’s National Ethics Research Committee No. 07/H0604/121.
3. Results
A total of 2599 adults (mean age 47.2 ± 14.5 years) had valid lung function estimates (Table 1).
With the exception of Belgians, the BMI for all participant countries indicated that the participants
were, on average, overweight. Around half of the participants reported never having smoked, whilst
just over 15% declared that they were current smokers. Nearly two-thirds of the sample studied
was defined as a ‘case’. Use of nutritional supplements varied across countries, with Finnish adults
reporting the highest proportion of intakes of nutritional supplements and Portuguese the lowest.
Intake of fruits and vegetables averaged three portions of each per person per day in the whole sample.
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Table 1. General characteristics of the study population (n = 2599) #.
Variables
Countries Participating in the GA2LEN Nutrition Survey
Denmark Finland Sweden UK Portugal
Odense (268) Helsinki (122) Total (1085) Total (139) Coimbra (233)
Age, years; mean (SD) 47.9 (14.2) 45.8 (14.5) 45.5 (15) 51.3 (13.2) 47.2 (14.5)
Males, n (%) 115 (42.9) 47 (38.5) 471 (43.4) 54 (38.8) 80 (34.3)
Height, m (SD) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.6 (0.1)
BMI (m2/kg) 26.9 (4.7) 26.5 (4.3) 26 (4.7) 27.8 (5.8) 26.6 (5.3)
Never smokers, n (%) 119 (44.4) 60 (49.2) 578 (53.3) 63 (45.3) 148 (63.5)
Ex-smokers, n (%) 71 (26.5) 30 (24.6) 366 (33.7) 55 (39.6) 51 (21.9)
Current smokers, n (%) 78 (29.1) 32 (26.2) 141 (13) 21 (15.1) 34 (14.6)
Cases/controls 180/88 62/60 774/311 95/44 169/64
* FVC, L 4.1 (1.0) 4.0 (1.0) 4.1 (1.0) 3.7 (1.0) 3.8 (1.0)
* FEV1/FVC 78.4 (8.6) 80 (7.9) 78.2 (8.6) 75.4 (10.8) 80.5 (8.3)
FVC < LLN, n (%) 36 (13.4) 10 (8.2) 141 (13) 20 (14.4) 16 (6.9)
FEV1/FVC < LLN, n (%) 32 (11.9) 6 (4.9) 130 (12) 25 (18) 25 (10.7)
Nutritional supplements, n (%) 107 (39.9) 52 (42.6) 285 (26.3) 49 (35.3) 15 (6.4)
Total fruit intake, g/day 328 (263.8) 278.2 (219.4) 320.7 (242.5) 328.8 (238.3) 549.2 (403.7)
Total vegetable intake, g/day 342.6 (223.8) 415.5 (297.5) 355.8 (206.8) 343.2 (207.8) 454.5 (321.1)
Variables
Countries Participating in the GA2LEN Nutrition Survey
Belgium Germany The Netherlands Poland Total
Ghent (107) Total (305) Amsterdam (174) Total (166) 2599
Age, years, mean (SD) 44.5 (14.4) 48.7 (15.2) 52.7 (13.6) 51.6 (15) 47.4 (14.8)
Males, n (%) 47 (43.9) 116 (38) 88 (50.6) 65 (39.2) 1083 (41.7)
Height, m (SD) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1)
BMI (m2/kg) 24.5 (4) 26.9 (5) 27.1 (4) 27.7 (5.2) 26.5 (4.8)
Never smokers, n (%) 60 (56.1) 148 (48.5) 70 (40.2) 79 (47.6) 1,325 (51)
Ex-smokers, n (%) 32 (29.9) 108 (35.4) 67 (38.5) 48 (28.9) 828 (31.9)
Current smokers, n (%) 15 (14) 49 (16.1) 37 (21.3) 39 (23.5) 446 (17.2)
Cases/Controls 60/47 142/163 111/63 108/58 1701/898
* FVC, L 4.3 (1.0) 3.9 (1.0) 4.1 (1.0) 3.8 (1.0) 4.0 (1.0)
* FEV1/FVC 79.4 (9.5) 78.8 (7.7) 77.1 (8.4) 77 (10.4) 78.3 (8.8)
FVC < LLN, n (%) 9 (8.4) 55 (18) 11 (6.3) 13 (7.8) 311 (12)
FEV1/FVC < LLN, n (%) 10 (9.3) 25 (8.2) 20 (11.5) 20 (12) 293 (11.3)
Nutritional supplements, n (%) 33 (30.8) 81 (26.6) 72 (41.4) 39 (23.5) 733 (28.2)
Total fruit intake, g/day 333.1 (235.1) 314.7 (273.2) 289.5 (211.8) 465.2 (466.9) 347.3 (291.2)
Total vegetable intake, g/day 244.8 (126.1) 261.9 (187.2) 224.5 (130.5) 482.8 (429.6) 349.1 (246.9)
FVC, forced vital capacity; FEV1, forced exhaled volume in 1 second; LLN, lower limit of normal. * Post-bronchodilator; SD standard deviation; ‘n’ number of participants; ‘%’ percentage;
# Based on individuals with complete dietary data and valid (quality controlled) lung function measurements.
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The distribution of total flavonoid intake is shown in Figure 1, and that of other subclasses
in Table 2. Overall, the median intake of total flavonoids was 291 mg/person/day. Germany and
Belgium had the lowest intake. Poland, the Netherlands, and Portugal had the highest intakes of total
flavonoids. The Scandinavian countries and the UK had an intermediate intake. The main contributors
to total flavonoid intake are summarised in Table 3. Fruits were the main source, followed by tea, wine,
chocolate, and vegetables. As expected, flavonoid polymers were the main source of flavonoids in
most food groups. Citrus fruits were the predominant source of flavonones. Fruits (mostly berries
and citrus) and wine were the main contributors of anthocyanins, whilst flavonols and flavones were
mainly derived from vegetables (Table 3).
The association between FVC and spirometric restriction (FVC < LLN) with flavonoids is presented
in Table 4. In the basic model (adjusted by height, age, and sex only), total flavonoid intake and several
most subclasses were positively associated with a 30 mL higher FVC. After controlling for further
confounders (BMI, whether a case or a control, intake of nutrient supplements, education, smoking
status, total fruit and vegetable intake, and TEI), these associations were attenuated and were no
longer statistically significant. With regards to spirometric restriction, a 42% lower risk of FVC
< LLN was observed in those with the highest quintile of total flavonoid intake (odds ratio (OR)
0.58; 95% CI 0.36, 0.94). Similarly, after adjusting for the full set of potential confounders, a 53%
lower risk of FVC < LLN was observed in those adults with the highest intake of anthocyanins and
pro-anthocyanidins. After applying the Simes’ procedure, the statistical significance of the adjusted
associations remained (Table 4).
Nutrients 2018, 10, 95 6 of 13 
 
The distribution of total flavonoid intake is shown in Figure 1, and that of other subclasses in 
Table 2. Overall, the median intake of total flavonoids was 291 g/person/day. Germany and 
B lgium had the lowest intake. Polan  the Netherlands, and Portugal had the highest intakes of total 
flavonoids. The Scandinavian countries and the UK had an intermediate intake. The main 
contributors to total flavonoid intake are summarised in Table 3. Fruits were the main source, 
followed by tea, wine, chocolate, and vegetables. As expected, flavonoid polymers were the main 
source of flavonoids in most food groups. Citrus fruits were the predominant source of flavonones. 
Fruits (mostly berries and citrus) and wine were the main contributors of anthocyanins, whilst 
flavonols and flavones were mainly derived from vegetables (Table 3). 
Th  association between FVC nd spirometric restrict on (FVC < LLN) with flavonoids is 
presented in Table 4. In the basic model (adjusted by height, age, and sex only), total flavonoid intake 
and several most subclasses were positively associated with a 30 mL higher FVC. After controlling 
for further confounders (BMI, whether a case or a control, intake of nutrient supplements, education, 
smoking status, total fruit and vegetable intake, and TEI), these associations were attenuated and 
were no longer statistically significant. With regards to spirometric restriction, a 42% lower risk of 
FVC < LLN was observed n those with the highest quintile of total flav noid intake (odds ratio (OR) 
0.58; 95% CI 0.36, 0.94). Similarly, after adjusting for the full set of potential confounders, a 53% lower 
risk of FVC < LLN was observed in those adults with the highest intake of anthocyanins and pro-
anthocyanidins. After applying the Simes’ procedure, the statistical significance of the adjusted 
associations remained (Table 4). 
 
Figure 1. Total flavonoid intake in the adults participating in the GA2LEN Follow-Up Survey who 
had valid lung function data (n = 2599). 
Table 5 shows the association between FEV1/FVC and FEV1/FVC < LLN with flavonoid intake. 
A higher FEV1/FVC was associated with a higher intake of flavonoids, polymers, and pro-
anthocyanidins. After Simes’ procedure, each of these associations remained statistically significant. 
Airflow obstruction (FEV1/FVC < LLN) was not associated with any of the flavonoid exposures 
studied. 
The meta-analyses in Figure 2 illustrate the adjusted associations between FEV1/FVC and total 
flavonols and pro-anthocyanidins per centre and the overall effect. These associations showed 
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Figure 1. Total flavonoid intake in the adults participating in the GA2LEN Follow-Up Survey who had
valid lung function data (n = 2599).
Table 5 shows the association between FEV1/FVC and FEV1/FVC < LLN with flavonoid intake.
A higher FEV1/FVC was associated with a higher intake of flavonoids, polymers, and pro-anthocyanidins.
After Simes’ procedure, each of these associations remained statistically significant. Airflow obstruction
(FEV1/FVC < LLN) was not associat d with ny of the flavonoid exposures studied.
The meta-analyses in Figure 2 illustrate the adjusted associations between FEV1/FVC and total
flavonols and pro-anthocyanidins per centre and the overall effect. These associations showed
evidence of moderate but not statistically significant evidence of heterogeneity between countries
in the analyses with pro-anthocyanidins (I2 = 38.2%, p-value = 0.10), whilst the meta-analysis for
pro-anthocyanidins showed no evidence of variations between countries, as reflected by the zero
heterogeneity in these associations.
Nutrients 2018, 10, 95 7 of 13
Table 2. Dietary intake of main flavonoid subclasses in adults from countries participating in GA2LEN.
Dietary Intake of Flavonoids across Countries (Median Intake in mg, IQR)
Flavonoid Subclass Denmark Finland Sweden UK Portugal
Odense (268) Helsinki (122) Total (1085) Total (139) Coimbra (233)
Total flavonoids 251.1 (106.3 to 479.7) 260.5 (95.2 to 427.2) 249.4 (113 to 439.1) 345.5 (140.3 to 848.8) 426.5 (215.8 to 749.1)
Flavanones 4.5 (1.3 to 20.9) 8.3 (1.8 to 23.6) 5.3 (1.4 to 21) 5 (1.8 to 18.3) 17.1 (2.9 to 60.3)
Anthocyanins 7.5 (2.4 to 16.3) 5.9 (2.1 to 13) 6.5 (2.1 to 15.1) 9.8 (3.7 to 30.3) 22.1 (6.9 to 47.5)
Flavan-3-ols 30.6 (14 to 69) 24.4 (10 to 56.3) 29.4 (13 to 65.3) 43.7 (14.8 to 183.5) 44 (20.9 to 78.2)
Flavanols 16.3 (9.3 to 29.3) 19.5 (10.8 to 33.1) 16.9 (9.2 to 28.2) 16.7 (9.1 to 32.7) 26.6 (12.9 to 44.6)
Flavones 2.1 (0.9 to 4.4) 2.4 (1.3 to 4.5) 2 (0.9 to 4.3) 1.7 (0.6 to 3.2) 2.6 (1.1 to 5.7)
Polymers 175.7 (66.1 to 316.3) 162.9 (62.5 to 260.2) 159.5 (66.4 to 283.3) 251.5 (75.7 to 601.5) 266.8 (106.5 to 459.8)
Pro-anthocyanidins 135.3 (68.6 to 261.1) 152.8 (58.7 to 270.7) 126.6 (62.9 to 245.7) 195.2 (76.7 to 376.6) 286.7 (113.1 to 465.1)
Dietary Intake of Flavonoids across Countries (Median Intake in mg, IQR)
Flavonoid Subclass Belgium Germany The Netherlands Poland Total
Ghent (107) Total (305) Amsterdam (174) Total (166) 2599
Total flavonoids 341.4 (113.9 to 489.4) 231.7 (110.2 to 413.8) 507 (242.1 to 867.4) 817.3 (341.6 to 1029.3) 291.2 (126.8 to 569.4)
Flavanones 10.3 (2.3 to 27.9) 4.9 (1.1 to 21.6) 7 (2.3 to 29) 6.7 (1.8 to 28) 5.7 (1.5 to 22.5)
Anthocyanins 10.5 (2.7 to 21) 5.5 (1.7 to 13.3) 8.1 (2.8 to 22.1) 9.2 (2.3 to 26.3) 7.5 (2.4 to 19.6)
Flavan-3-ols 32.9 (13.6 to 83.8) 38.1 (13.2 to 77.3) 84.1 (35.5 to 186.2) 176.3 (54.9 to 200.1) 37.9 (15.4 to 90.4)
Flavanols 13.1 (7 to 23.7) 11 (5.2 to 20.2) 17.8 (9.2 to 30.6) 34 (21.3 to 51.8) 17.2 (9.2 to 30.8)
Flavones 1.4 (0.5 to 2.5) 1.1 (0.4 to 2.3) 1.5 (0.6 to 2.5) 2.1 (0.7 to 5.8) 1.9 (0.7 to 3.9)
Polymers 216.5 (71.1 to 325.5) 132.1 (63.7 to 268.1) 341.7 (129.5 to 622.3) 585.9 (243 to 687.5) 198.4 (72.9 to 375.2)
Pro-anthocyanidins 214.9 (80.5 to 343.8) 136.1 (69 to 261.4) 190.8 (101.5 to 327.8) 192.7 (105.5 to 311.8) 154.6 (72.5 to 284.3)
IQR: interquartile range.
Table 3. Provenance and contribution of flavonoid subclasses in the diet of participants in the GA2LEN Follow-Up Study.
Food Groups (mg/% Total Dietary Sources)
Flavonoid Subclasses (mg) All Fruit Citrus Fruit Hard Fruit Berries Other Fruit Vegetables Chocolate Nuts Legumes Tea & Coffee Wine & Beer
Total flavonoids 289.93 36.58 124.08 2.91 64.09 14.9 30.87 1.43 0.23 152.9 21.07
Flavanones 7.51% 59.21% 0.00% 0.10% 0.19% 2.08% 0.00% 0.06% 0.00% 0.00% 2.47%
Anthocyanins 5.66% 9.00% 4.38% 28.94% 13.18% 1.96% 0.00% 2.59% 0.42% 0.00% 9.43%
Flavan-3-ols 6.86% 1.58% 7.07% 4.61% 8.93% 0.00% 16.33% 3.26% 21.38% 31.41% 26.85%
Flavonols 3.45% 1.49% 4.41% 1.17% 1.87% 79.15% 0.00% 1.38% 21.62% 2.91% 9.00%
Flavones 0.34% 1.62% 0.14% 0.45% 0.29% 16.81% 0.00% 0.00% 0.00% 0.00% 1.23%
Polymers 76.18% 27.11% 84.02% 64.74% 75.54% 0.00% 83.67% 92.71% 56.59% 65.68% 51.02%
Pro-anthocyanidins 234.07 10.11 110.84 1.98 50.75 0.00 34.64 1.40 0.18 15.1 14.92
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Table 4. Association of post-bronchodilator spirometric values of FVC and FVC < LLN with dietary intake of flavonoids.
Flavonoid Subclass
(Quintiles; mg)
FVC (Lt) (Continuous) FVC < LLN (Binary)
Effect Size (Regression Coefficient and 95% Confidence Interval) Per-Quintile
Increase in Flavonoid Intake OR (95% Confidence Interval) Highest Vs. Lowest Quintile of Flavonoid Intake
Model 1 (n = 2599) p-Value Model 2 (n = 2599) p-Value Model 1 (n = 2599) p-Value Model 2 (n = 2599) p-Value p-Value afterSimes’ Procedure
Total flavanoids 0.03 (0.02 to 0.05) <0.0001 0.02 (−0.002 to 0.03) 0.09 0.47 (0.31 to 0.71) <0.0001 0.58 (0.36 to 0.94) 0.03 0.07
Flavanones 0.03 (0.02 to 0.05) <0.0001 0.02 (−0.002 to 0.03) 0.08 0.47 (0.31 to 0.71) 0.0003 0.60 (0.37 to 0.97) 0.04 0.07
Anthocyanins 0.04 (0.02 to 0.05) <0.0001 0.02 (−0.01 to 0.04) 0.14 0.37 (0.24 to 0.57) <0.0001 0.47 (0.26 to 0.83) 0.01 0.04
Flavan-3-ols 0.02 (0.002 to 0.03) 0.03 <0.001 (−0.02 to 0.02) 0.97 0.58 (0.39 to 0.86) 0.01 0.75 (0.49 to 1.14) 0.17
Flavonols 0.03 (0.02 to 0.05) 0.0001 0.01 (−0.004 to 0.03) 0.12 0.52 (0.35 to 0.76) 0.0008 0.66 (0.41 to 1.04) 0.07
Flavones 0.02 (0.01 to 0.04) 0.003 0.01 (−0.01 to 0.02) 0.54 0.58 (0.40 to 0.85) 0.01 0.79 (0.51 to 1.22) 0.28
Polymers 0.03 (0.02 to 0.05) 0.0001 0.01 (−0.003 to 0.03) 0.10 0.52 (0.34 to 0.79) 0.002 0.65 (0.41 to 1.04) 0.07
Pro-anthocyanidins 0.04 (0.02 to 0.05) <0.0001 0.02 (−0.002 to 0.04) 0.07 0.41 (0.26 to 0.63) 0.0001 0.47 (0.27 to 0.81) 0.01 0.04
Model 1 Adjusted by height, age, and sex; Model 2 Adjusted by height, age, sex, whether a case or a control, BMI, smoking status (never, ex-smoker, current smoker), occupation, age at
completion of full time education, use of nutritional supplements, total fruit intake, and total energy intake (TEI), Lt: liters.
Table 5. Association of post-bronchodilator ratio FEV1/FVC and FEV1/FVC < LLN with dietary intake of flavonoids.
Flavonoid Subclass
(Quintiles; mg)
FEV1/FVC (Continuous) FEV1/FVC < LLN (Binary)
Effect Size (Regression Coefficient and 95% Confidence Interval) Per-Quintile
Increase in Flavonoid Intake
OR (95% Confidence Interval) Highest vs. Lowest Quintile of
Flavonoid Intake
Model 1 (n = 2599) p-Value Model 2 (n = 2599) p-Value
p-Value
after Simes’
Procedure
Model 1 (n = 2599) p-Value Model 2 (n = 2599) p-Value
p-Value
after Simes’
Procedure
Total flavanoids 0.50 (0.29 to 0.72) <0.0001 0.33 (0.10 to 0.57) 0.01 0.02 0.58 (0.39 to 0.86) 0.01 0.61 (0.39 to 0.97) 0.04 0.12
Flavanones 0.16 (−0.05 to 0.37) 0.15 0.07 (−0.30 to 0.17) 0.57 0.71 (0.47 to 1.08) 0.11 0.84 (0.51 to 1.37) 0.49
Anthocyanins 0.34 (0.13 to 0.56) 0.002 0.12 (−0.15 to 0.39) 0.39 0.58 (0.39 to 0.86) 0.01 0.73 (0.43 to 1.24) 0.25
Flavan-3-ols 0.42 (0.21 to 0.63) 0.0001 0.20 (−0.02 to 0.42) 0.07 0.65 (0.44 to 0.97) 0.03 0.73 (0.47 to 1.11) 0.14
Flavonols 0.34 (0.13 to 0.56) 0.002 0.18 (−0.06 to 0.42) 0.14 0.77 (0.52 to 1.14) 0.19 0.92 (0.58 to 1.47) 0.74
Flavones 0.31 (0.1 to 0.52) 0.004 0.17 (−0.07 to 0.4) 0.16 0.80 (0.54 to 1.18) 0.26 1.01 (0.63 to 1.6) 0.97
Polymers 0.48 (0.27 to 0.69) <0.0001 0.32 (0.09 to 0.55) 0.01 0.02 0.55 (0.37 to 0.81) 0.002 0.56 (0.36 to 0.88) 0.01 0.09
Pro-anthocyanidins 0.58 (0.37 to 0.79) <0.0001 0.44 (0.19 to 0.69) 0.001 0.004 0.58 (0.39 to 0.85) 0.01 0.61 (0.37 to 0.99) 0.04 0.12
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Figure 2. The association of FEV1/FVC and intakes (mg) of pro-anthocyanidins (a) and flavonols (b)
(Meta-analysis of adjusted effect estimates (β-coefficient); n = 2599).
4. Discussion
This multi-centric population-based study in European adults showed that those with a higher intake
of pro-anthocyanidins, had a higher FEV1/FVC, a lower risk of airway obstruction (FEV1/FVC < LLN)
and a lower risk of spirometric restriction (FVC < LLN). Total flavonoid intake was also associated with
a higher FEV1/FVC and with a lower risk of spirometric restriction. The statistical significance of each
of these associations remained after applying Simes’ procedure, with the exception of the associations
observed with FEV1/FVC < LLN. The direction of these associations was fairly consistent across countries,
with moderate or no evidence of heterogeneity between them.
To our knowledge, this is the first multi-national population-based study to examine the
association between objective measures of airway restriction and obstruction with the intake of
a wide range of flavonoids. Our results suggest that a higher intake of flavonoids might contribute to
a better ventilatory function and reduce the risk of spirometric restriction. Two other observational
studies have suggested this, although they examined three subclasses of flavonoids, and the effect of
pro-anthocyanidins was not investigated. The study of Garcia-Larsen recently showed that catechin
intake was associated with a 70 mL higher FVC in a population-based study of young adults, when
comparing those in the highest versus the lowest quintile of intake [14]. Similarly, Tabak et al. showed
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that total intake of catechins was associated with a 43 mL higher FEV1 and negatively associated with
self-reported symptoms in Dutch adults [25].
After controlling for multiple comparisons, our results showed no evidence of an association with
airflow obstruction, but with spirometric restriction. FVC has been linked more strongly to survival and
to comorbidities than airflow obstruction [26]. This remains largely unexplained, other than a strong
relation to early life factors such as birth weight. The fact that a beneficial association was observed
with FVC < LLN and not with measures of airway obstruction, suggest that pro-anthocyanidins might
contribute to preserving ventilatory function and might, in turn, prevent an accelerated decline of FVC,
thus reducing the risk of general mortality and co-morbidities [27]. Although such an effect would
need to be confirmed in longitudinal studies, the findings in the GA2LEN population justify the need
for such studies.
Mechanistic effects from experimental studies support our findings. An experimental study using
a mouse model to investigate the effect of pro-anthocyanidins on lung inflammation showed that the
animals fed with this flavonoid had a significantly reduced production of pro-inflammatory cytokines
produced by Th2 cells [2]. The antioxidant activity of pro-anthocyanidins has also been demonstrated
in murine model of induced allergic asthma [3,26], where mice treated with the flavonoid extract had
significantly lower nitric oxide levels [3], airway hyper-responsiveness [26], and their lung tissue levels
of various cytokines, chemokines, and growth factors were lower than those in the mice that did not
receive the pro-anthocyanidin extract [27]. In human alveolar cells, pro-anthocyanidin extract has been
shown to reduce the IL-4-dependent eosinophil expression [5].
Earlier evidence in humans and rodents showing that flavonoids are poorly absorbed and often
excreted un-metabolised [28], has been reappraised in the light of more recent studies. The study
of Czek and colleagues showed that specific flavonoids such as anthocyanidins are metabolised to
a structurally diverse range of metabolites [29], and that these circulate in plasma in adults for up to
48 hours after ingestion [30]. In animals fed with procyanidin-enriched supplement, metabolites of
pro-anthocyanidins (mainly glucoronide forms of epicatechins) were detected in plasma and also found
in lung tissue, up to 18 h after ingestion [31]. Metabolites of anthocyanins have also been detected
after experimental ingestion in animals [32,33]. These findings suggest that the bioavailability of
flavonoids expands beyond the gastro-intestinal tract and that they might play a key role in a number
of anti-inflammatory processes in the airways [34].
In the GA2LEN study, we observed that with the exception of Germany, there was a consistent
trend across countries for a reduced risk of spirometric restriction with higher in those with the highest
intakes of pro-anthocyanidins, with no statistically significant evidence of heterogeneity. The risk
reduction of 57% has clinical and public health relevance. The intake of pro-anthocyanidins in the
GA2LEN participants was on average 192 mg and came largely from fruit intake. This amount can
be achieved by eating 3–4 units of hard fruits a day, which is an attainable target in the general
adult population. The statistical significance of this association was retained after applying Simes’
procedure. Although the statistical significance of the positive association between FVC and intake of
pro-anthocyanidins was attenuated after Simes’ procedure, the size of the effect, and the consistent
trend across countries found in this study, would confirm the laboratory evidence showing a protective
effect of these specific flavonoids.
The associations between flavonoid subclasses and respiratory outcomes were controlled for use
of nutritional supplements. Nearly a third of the participants in this study reported taking nutritional
supplements, a strong trend widespread in Europe [35]. Bioactive forms of various polyphenols,
including flavonoids, are often present in nutritional supplements, and our results are unlikely to be
explained by this use.
The strengths of the current study include that we used a representative sample of the European
adult population and used several measures of airway restriction and airway obstruction that
underwent rigorous quality control before being considered acceptable. We also assessed a wide
range of flavonoid subclasses. Dietary flavonoid intakes were calculated from a database developed
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using recent USDA databases for flavonoids and pro-anthocyanidins [21,22]. These datasets allowed
us to quantify a broad range of flavonoid subclass intakes providing more robust evidence than
previous studies on flavonoid intake and lung diseases. The FFQ used in the current study included
a comprehensive list of fruits and vegetables, as well as other dietary sources known to have flavonoids.
The FFQ was validated in a sample of this study population [17] and reflects the usual dietary intake
of these individuals as well as facilitating international comparisons. We also validated the FFQ for
intake of flavonoids and found that the FFQ is an accurate instrument to capture dietary sources of
flavonoids [36].
This study has some limitations. High flavonoid intake may be representative of a healthy lifestyle
in general, and although we adjusted for a range of lifestyle variables, as well as fruit and vegetable
intake, residual or unmeasured confounding cannot be ruled out. The cross-sectional nature of our
study prevents us from establishing a causal inference in the association between flavonoids and lung
function. However, recent longitudinal findings from the elderly adults from the Normative Aging
Study showed that a higher intake of anthocyanins was associated with slower FVC decline over
15 years [37], which lends further support to our hypothesis that a higher intake of flavonoids might
preserve lung function and possibly reduce the risk of COPD. Epidemiological studies on lung health
and flavonoids are still scant, with the exception of lung cancer, for which there is increasing evidence
of a protective role of dietary flavonoids [38]. Replications of our findings in longitudinal studies are
warranted to confirm the role in reducing the risk of lung disease.
5. Conclusions
In conclusion, this study provides for the first time, observational evidence for a positive
association of pro-anthocyanidins and possibly total flavonoid intake and lung function in
a multi-centric sample of European adults. The magnitude of the effect is clinically significant
and of public health relevance. Increasing the consumption of dietary sources of flavonoids is an
achievable target and can contribute to maintaining lung function, and possibly to preventing its
accelerated decline.
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